COVID-19 and linked restrictions have likely\ua0impacted drug supply, use and harms\ua0and challenged\ua0drug treatment/harm reduction services. People who use drugs may be at increased risk of COVID-19 transmission because of the social nature of drug procurement/use. There have been urgent calls for evidence regarding the experiences of people who use drugs during the pandemic to inform public health efforts. EDRS\ua0is an illicit drug monitoring system, operating\ua0in Australia since 2003, including\ua0annual interviews with people who regularly use ecstasy/other illicit stimulants. Recognising the critical need for information, EDRS was adapted to collect important data on people’s experiences during COVID-19. This output presents find...
The Ecstasy and Related Drugs Reporting System (EDRS) is an annual, national study funded by the Aus...
Introduction: The Ecstasy and Related Drugs Reporting System (EDRS) is an annual, national study fun...
This report describes annual data and 20-year trends in the use of ecstasy and related drugs, harms ...
The COVID-19 pandemic and restrictions on travel and gathering have likely had major impacts on drug...
Aims: To describe (i) self-reported changes in drug use and (ii) trends in price, perceived availabi...
Background and aims: Few studies of the impacts of COVID-19 public health measures on drug markets a...
The Ecstasy and Related Drugs Reporting System (EDRS) is conducted every year in the capital city of...
Methamphetamine, MDMA, cocaine, cannabis, and alcohol in samples from 20 wastewater treatment plants...
The Ecstasy and Related Drugs Reporting System (EDRS) is an illicit drug monitoring system which has...
Public commentary has offered mixed opinion on the likely impact of COVID-19 restrictions on drug-re...
This study examines the methamphetamine market and prevalence of methamphetamine use in Perth during...
Aims: This paper examines the epidemiology of ecstasy use and harm in Australia using multiple data ...
Aims:This paper examines the epidemiology of ecstasy use and harm in Australia using multiple data s...
Background and aims COVID-19 has infected more than 13 million people worldwide and impacted the liv...
The Australians' Drug Use: Adapting to Pandemic Threats (ADAPT) Study is exploring the short and lon...
The Ecstasy and Related Drugs Reporting System (EDRS) is an annual, national study funded by the Aus...
Introduction: The Ecstasy and Related Drugs Reporting System (EDRS) is an annual, national study fun...
This report describes annual data and 20-year trends in the use of ecstasy and related drugs, harms ...
The COVID-19 pandemic and restrictions on travel and gathering have likely had major impacts on drug...
Aims: To describe (i) self-reported changes in drug use and (ii) trends in price, perceived availabi...
Background and aims: Few studies of the impacts of COVID-19 public health measures on drug markets a...
The Ecstasy and Related Drugs Reporting System (EDRS) is conducted every year in the capital city of...
Methamphetamine, MDMA, cocaine, cannabis, and alcohol in samples from 20 wastewater treatment plants...
The Ecstasy and Related Drugs Reporting System (EDRS) is an illicit drug monitoring system which has...
Public commentary has offered mixed opinion on the likely impact of COVID-19 restrictions on drug-re...
This study examines the methamphetamine market and prevalence of methamphetamine use in Perth during...
Aims: This paper examines the epidemiology of ecstasy use and harm in Australia using multiple data ...
Aims:This paper examines the epidemiology of ecstasy use and harm in Australia using multiple data s...
Background and aims COVID-19 has infected more than 13 million people worldwide and impacted the liv...
The Australians' Drug Use: Adapting to Pandemic Threats (ADAPT) Study is exploring the short and lon...
The Ecstasy and Related Drugs Reporting System (EDRS) is an annual, national study funded by the Aus...
Introduction: The Ecstasy and Related Drugs Reporting System (EDRS) is an annual, national study fun...
This report describes annual data and 20-year trends in the use of ecstasy and related drugs, harms ...